Seckl MJ - Search Results

1

Diagnosis and management of gestational trophoblastic disease: 2021 update.

Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, Lurain JR, Massuger L. Ngan HYS, et al. Among authors: seckl mj. Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):86-93. doi: 10.1002/ijgo.13877. Int J Gynaecol Obstet. 2021. PMID: 34669197 Free PMC article.

2

Treatment of gestational trophoblastic disease.

Seckl MJ, Newlands ES. Seckl MJ, et al. Gen Diagn Pathol. 1997 Nov;143(2-3):159-71. Gen Diagn Pathol. 1997. PMID: 9443572 Review.

3

Management of resistant gestational trophoblastic tumors.

Newlands ES, Bower M, Holden L, Short D, Seckl MJ, Rustin GJ, Begent RH, Bagshawe KD. Newlands ES, et al. Among authors: seckl mj. J Reprod Med. 1998 Feb;43(2):111-8. J Reprod Med. 1998. PMID: 9513872

4

Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome.

Woolas RP, Bower M, Newlands ES, Seckl M, Short D, Holden L. Woolas RP, et al. Br J Obstet Gynaecol. 1998 Sep;105(9):1032-5. doi: 10.1111/j.1471-0528.1998.tb10271.x. Br J Obstet Gynaecol. 1998. PMID: 9763059

5

Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.

Newlands ES, Mulholland PJ, Holden L, Seckl MJ, Rustin GJ. Newlands ES, et al. Among authors: seckl mj. J Clin Oncol. 2000 Feb;18(4):854-9. doi: 10.1200/JCO.2000.18.4.854. J Clin Oncol. 2000. PMID: 10673528

6

Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age.

Sebire NJ, Foskett M, Fisher RA, Rees H, Seckl M, Newlands E. Sebire NJ, et al. BJOG. 2002 Jan;109(1):99-102. doi: 10.1111/j.1471-0528.2002.t01-1-01037.x. BJOG. 2002. PMID: 11843379

7

The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumours.

Blagden SP, Foskett MA, Fisher RA, Short D, Fuller S, Newlands ES, Seckl MJ. Blagden SP, et al. Among authors: seckl mj. Br J Cancer. 2002 Jan 7;86(1):26-30. doi: 10.1038/sj.bjc.6600041. Br J Cancer. 2002. PMID: 11857007 Free PMC article.

8

Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.

McNeish IA, Strickland S, Holden L, Rustin GJ, Foskett M, Seckl MJ, Newlands ES. McNeish IA, et al. Among authors: seckl mj. J Clin Oncol. 2002 Apr 1;20(7):1838-44. doi: 10.1200/JCO.2002.07.166. J Clin Oncol. 2002. PMID: 11919242

9

Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.

Sebire NJ, Fisher RA, Foskett M, Rees H, Seckl MJ, Newlands ES. Sebire NJ, et al. Among authors: seckl mj. BJOG. 2003 Jan;110(1):22-6. BJOG. 2003. PMID: 12504931

10

Persistent gestational trophoblastic disease is rarely, if ever, derived from non-molar first-trimester miscarriage.

Sebire NJ, Foskett M, Fisher RA, Lindsay I, Seckl MJ. Sebire NJ, et al. Among authors: seckl mj. Med Hypotheses. 2005;64(4):689-93. doi: 10.1016/j.mehy.2004.11.032. Med Hypotheses. 2005. PMID: 15694683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

248 results

Search Page